[The therapeutic value of "Essential" phospholipids].
43 male and 30 female patients with various types of hyperlipemia were treated with Lipostabil, Lipostabil forte and 2 placebo preparations, each treatment lasting one month. The effect on the serum lipid level, lipoprotein electrophoresis, coagulation, coronary and peripheral vascular diseases, blood pressure and glucose tolerance was examined. Lipostabil caused a significant decrease of the serum triglyceride level in Type IV. To us, the use of "Essential" phospholipids alone does not appear to be sufficient for the drug therapy of hyperlipemia, but it might play a supporting role in the treatment.
D000328:Adult; D000368:Aged; D001777:Blood Coagulation; D001794:Blood Pressure / Q000187:drug effects; D001797:Blood Protein Electrophoresis; D001835:Body Weight / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease; D004562:Electrocardiography; D005121:Extremities; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D010743:Phospholipids / Q000494:pharmacology / Q000627:therapeutic use*; D010919:Placebos; D012039:Regional Blood Flow / Q000187:drug effects; D013916:Thrombelastography; D014280:Triglycerides / Q000097:blood
D008055:Lipids; D008074:Lipoproteins; D010743:Phospholipids; D010919:Placebos; D014280:Triglycerides; D002784:Cholesterol
Zum therapeutischen Wert der "essentiellen" Phospholipide